After a period of exponential growth and record-breaking market indicators throughout 2020 and 2021, 2022 marked a period of stabilization for Greater Boston’s life sciences market. While the momentum continued throughout the first half of the year, activity slowed during the third and fourth quarters as demand cooled.
While the market will face headwinds in the coming year amidst an uncertain economic climate, Greater Boston is well-positioned to remain a top-tier life sciences market.
Boston Biostatus January 2023
Riley McMullan • 1/31/2023
Insights in your Inbox
Subscribe to the latest local market research, insights and analysis from Cushman & Wakefield across the United States.
Subscribe
Related Insights
Article
Does your building qualify for a life sciences conversion?
Interest in converting assets for life sciences use is growing amongst building owners. Cushman & Wakefield’s Project & Development Services team developed basic building performance criteria based on the minimum standards that life sciences companies typically require.
Eric Giles • 7/18/2023
Research
Life Sciences Update: March 2023
Accelerated growth in the life sciences sector has translated into double-digit rent growth, single-digit vacancy rates, and strong investment flows in the last ten years.
Sandy Romero • 3/20/2023
Article
Identifying Opportunities in Boston’s Life Science Market
Boston’s life sciences market has experienced exponential growth in the last five years but recent volatility in the equity markets has resulted in falling market capitalization for many companies.
Sandy Romero • 5/25/2022
Related Industries
Life Sciences
Our life sciences real estate experts drive customized, dynamic solutions for investors, owners, developers and occupiers within the quickly evolving life sciences sector.
Learn More